
==== Front
BMJBMJBMJ-UKbmjThe BMJ0959-81381756-1833BMJ Publishing Group Ltd. Correction126610.1136/bmj.l6213CorrectionsAnticholinergic drugs and risk of dementia: case-control study 2019 31 10 2019 31 10 2019 367 l6213Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions2019BMJThis is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
==== Body
An error occurred in this paper by Richardson and colleagues (BMJ 2018;361:k1315, doi:10.1136/bmj.k1315, published 25 April 2018). The corresponding authorâ€™s email address should be kathryn.richardson@uea.ac.uk. The paper and PDF will be updated in due course.

